Related Experiment Video
Updated: Apr 1, 2026

Quantification of Atherosclerosis in Mice
Published on: June 12, 2019
CD36 as a biomarker of atherosclerosis
Burak Yazgan1, Seyfettin Ustunsoy1, Betul Karademir1
1Department of Biochemistry, Faculty of Medicine, Genetic and Metabolic Diseases Research Center, Marmara University, Istanbul, Turkey.
Insights
CD36 mRNA levels in peripheral blood mononuclear cells can indicate atherosclerosis progression. This finding suggests a potential non-invasive diagnostic marker for the chronic inflammatory arterial disease.
Area of Science:
- Cardiovascular Biology
- Immunology
- Molecular Medicine
Background:
- Atherosclerosis is a chronic inflammatory disease characterized by arterial wall damage, smooth muscle cell proliferation, and plaque formation.
- Oxidized low-density lipoproteins (oxLDL) are key drivers, activating cellular responses and contributing to atherosclerotic plaque development.
- Scavenger receptors, particularly CD36, play a critical role by binding oxLDL and mediating lipid transport in macrophages and foam cells within lesions.
Purpose of the Study:
- To investigate the correlation between CD36 mRNA expression in aortic tissue and peripheral blood mononuclear cells (PBMCs) in a cholesterol-induced atherosclerosis model.
- To determine if CD36 mRNA levels in PBMCs can serve as a surrogate marker for atherosclerosis in aortic tissue.
Main Methods:
- Cholesterol-induced atherosclerosis was established in rabbits.
- CD36 mRNA expression was quantified in both aortic tissue and PBMCs.
- Macroscopic and microscopic examinations were used to assess atherosclerotic lesions.
Main Results:
- Cholesterol-fed rabbits developed typical atherosclerotic lesions in their aortas.
- CD36 mRNA expression was significantly increased in the aortas of these rabbits.
- Importantly, CD36 mRNA levels in PBMCs were found to correlate with those in the aortic tissue.
Conclusions:
- CD36 mRNA expression in PBMCs serves as a reliable indicator of CD36 mRNA levels in the aorta during cholesterol-induced atherosclerosis.
- PBMC CD36 mRNA levels may represent a valuable, non-invasive biomarker for diagnosing and monitoring atherosclerosis.
Abstract:
Atherosclerosis is a chronic inflammatory disorder occurs as a result of mononuclear lymphocyte infiltration to the arterial wall accompanied by smooth muscle cell proliferation and damage in the arterial wall caused by extracellular matrix accumulation. Besides several genetic and environmental factors, increased serum cholesterol and oxidized low density lipoproteins are considered to be major risk factors of the disease. During atherosclerosis, lipoproteins such as LDL become trapped at the site of lesion and are converted to oxLDL. Smooth muscle cells become activated by oxLDL, start to proliferate, and migrate into the intima of the arterial wall. OxLDL provokes a cascade of cellular responses at the atherosclerotic lesion, ultimately leading to formation of atherosclerotic plaques. In this process, scavenger receptors could play a critical role because of their ability to bind oxLDL and their function in transporting lipids and cholesterol into and out of the cells. Scavenger receptors are expressed on macrophages and foam cells in atherosclerotic lesions. CD36 is the most important one among them playing role in atherosclerotic process. CD36 is a raft associated glycosylated protein with an 88kDa molecular weight and various ligands such as oxLDL, apoptotic cells, advanced glycation end products bind to this receptor. It has been shown that mice knockouts for the apolipoprotein E exhibited a marked decrease in atherosclerotic lesions if CD36 gene was made inactive. Previously we have shown that the aortas of cholesterol-fed rabbits showed typical atherosclerotic lesions, detected by macroscopic and microscopic examination, and exhibited an increase in CD36 mRNA expression. In this study, we planned to compare CD36 mRNA expressions in the aortic tissue and peripheral blood mononuclear cells in cholesterol induced atherosclerosis. Our results suggests that CD36 mRNA levels in peripheral blood mononuclear cells reflect the levels in aorta and this might be used as a marker for diagnosis of atherosclerosis.
More Related Videos
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
07:20Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
Published on: January 28, 2014
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT